Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Dyslipidemia

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 17 articles: HTML format

Single Articles

February 2026
1. NAVAR AM, Mikhailova E, Catapano AL, Banka P, et al
   A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide.
   N Engl J Med. 2026;394:529-539.
   PubMed     Abstract available
   
   
   
2. SCHUNKERT H, Natarajan P, Samani NJ
   The Inherited Basis of Coronary Artery Disease.
   N Engl J Med. 2026;394:576-587.
   PubMed     Abstract available
   
   
   November 2025
3. LAFFIN LJ, Nicholls SJ, Scott RS, Clifton PM, et al
   Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3.
   N Engl J Med. 2025;393:2119-2130.
   PubMed     Abstract available
   
   
   
4. MARSTON NA, Bergmark BA, Alexander VJ, Prohaska TA, et al
   Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk.
   N Engl J Med. 2025 Nov 8. doi: 10.1056/NEJMoa2512761.
   PubMed     Abstract available
   
   
   August 2025
5. BERGMARK BA, Marston NA, Prohaska TA, Alexander VJ, et al
   Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia.
   N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2507227.
   PubMed     Abstract available
   
   
   July 2025
6. MCFARLAND R, Hyslop LA, Feeney C, Pillai RN, et al
   Mitochondrial Donation in a Reproductive Care Pathway for mtDNA Disease.
   N Engl J Med. 2025;393:461-468.
   PubMed     Abstract available
   
   
   May 2025
7. NICHOLLS SJ, Nelson AJ, Ditmarsch M, Kastelein JJP, et al
   Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk.
   N Engl J Med. 2025 May 7. doi: 10.1056/NEJMoa2415820.
   PubMed     Abstract available
   
   
   March 2025
8. MAGNUSSEN C, Alegre-Diaz J, Al-Nasser LA, Amouyel P, et al
   Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.
   N Engl J Med. 2025 Mar 30. doi: 10.1056/NEJMoa2415879.
   PubMed     Abstract available
   
   
   September 2024
9. WATTS GF, Rosenson RS, Hegele RA, Goldberg IJ, et al
   Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.
   N Engl J Med. 2024 Sep 2. doi: 10.1056/NEJMoa2409368.
   PubMed     Abstract available
   
   
   August 2024
10. FABBRINI E, Rady B, Koshkina A, Jeon JY, et al
    Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD.
    N Engl J Med. 2024;391:475-476.
    PubMed    
    
    
    May 2024
11. ROSENSON RS, Gaudet D, Hegele RA, Ballantyne CM, et al
    Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia.
    N Engl J Med. 2024 May 29. doi: 10.1056/NEJMoa2404147.
    PubMed     Abstract available
    
    
    
12. BALLANTYNE CM, Vasas S, Azizad M, Clifton P, et al
    Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia.
    N Engl J Med. 2024 May 28. doi: 10.1056/NEJMoa2404143.
    PubMed     Abstract available
    
    
    April 2024
13. BERGMARK BA, Marston NA, Prohaska TA, Alexander VJ, et al
    Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk.
    N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2402309.
    PubMed     Abstract available
    
    
    
14. WATTS GF
    Shooting the Messenger to Treat Hypertriglyceridemia.
    N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMe2402653.
    PubMed    
    
    
    
15. STROES ESG, Alexander VJ, Karwatowska-Prokopczuk E, Hegele RA, et al
    Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.
    N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2400201.
    PubMed     Abstract available
    
    
    February 2024
16. ALEXANDER VJ, Karwatowska-Prokopczuk E, Prohaska TA, Li L, et al
    Volanesorsen to Prevent Acute Pancreatitis in Hypertriglyceridemia.
    N Engl J Med. 2024;390:476-477.
    PubMed    
    
    
    April 2023
17. ALEXANDER JH
    Benefits of Bempedoic Acid - Clearer Now.
    N Engl J Med. 2023;388:1425-1426.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum